Type 1 Diabetes Trial, Recruiting (NCT06272136)

Type 1 Diabetes Trial, Recruiting NCT06272136 Sponsor: Liom Health AG Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06272136 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been officially diagnosed with type 1 or type 2 diabetes for at least 1 year
You are between 18 and 65 years old (inclusive)
You are currently managing your diabetes using insulin injections, insulin pumps, a hybrid closed-loop system (an automated insulin delivery device), and/or diabetes tablets (type 2 diabetes only)

Who may not be able to join:

You have a known or suspected allergy or sensitivity to any part of the Liom Clinical Demo 2.0 device used in this trial
You have any injury, infection, unusual skin condition (such as thickened or darkened skin), or a tattoo on your wrists
You have a history of, or currently have, a heart or cardiovascular condition — including chest pain (stable or unstable), heart attack, mini-stroke (TIA), stroke, heart failure, significant irregular heartbeat, or significant problems with your heart's electrical system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc Stoffel, MD, Profil for Stoffwechselforschung GmbH, Neuss, Germany

Phone: 0041 41 552 00 59

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06272136

Sponsor: Liom Health AG

Phase: Not Applicable

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 0041 41 552 00 59

More information: https://clinicaltrials.gov/study/NCT06272136

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been officially diagnosed with type 1 or type 2 diabetes for at least 1 year
You are between 18 and 65 years old (inclusive)
You are currently managing your diabetes using insulin injections, insulin pumps, a hybrid closed-loop system (an automated insulin delivery device), and/or diabetes tablets (type 2 diabetes only)

Who may not be able to join:

You have a known or suspected allergy or sensitivity to any part of the Liom Clinical Demo 2.0 device used in this trial
You have any injury, infection, unusual skin condition (such as thickened or darkened skin), or a tattoo on your wrists
You have a history of, or currently have, a heart or cardiovascular condition — including chest pain (stable or unstable), heart attack, mini-stroke (TIA), stroke, heart failure, significant irregular heartbeat, or significant problems with your heart's electrical system

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Liom Health AG

Registry

ClinicalTrials.gov

Start date

23 February 2024

Est. completion

21 July 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Glucose changes will be measured noninvasively and transcutaneously in dynamic states of glycaemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov